This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Takeda Pharmaceutical Company Ltd
Drug Names(s): Lapaquistat
Description: TAK-475 is an inhibitor of squalene synthase, an enzyme in the cholesterol synthesis pathway. Squalene synthase acts further down the cholesterol synthesis pathway than HMG CoA Reductase, and as a result, may avoid certain toxicities of statins.
Additional information available to subscribers only: